Drug Profile
Penehyclidine
Alternative Names: Changtuoning; Penehyclidine hydrochloride; PenequinineLatest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Chengdu List Pharmaceutical
- Class Quinuclidines
- Mechanism of Action Cholinergic receptor antagonists; NF-kappa B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Poisoning; Sedation
- No development reported Shock; Spasm; Tremor
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for clinical-Phase-Unknown development in Shock in China (PO, Tablet)
- 28 Jun 2019 No recent reports of development identified for clinical-Phase-Unknown development in Spasm in China (PO, Tablet)
- 28 Jun 2019 No recent reports of development identified for clinical-Phase-Unknown development in Tremor in China (PO, Tablet)